Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (4)
British Journal of Cancer (2)
Blood Cancer Journal (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (8)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Diseases
Genetics
Immunology
Medical research
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Fritz Offner Clear advanced filters

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

In a prespecified interim analysis of a pivotal phase 2 trial, tisagenlecleucel, an autologous CD19-targeting CAR-T cell therapy, produced a high rate of complete responses with a manageable safety profile in adults with relapsed or refractory follicular lymphoma

Nathan Hale Fowler
Michael Dickinson
Catherine Thieblemont
Research17 Dec 2021
Nature Medicine

Volume: 28, P: 325-332
Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

Marinus van Oers
Lukas Smolej
Christian Geisler
ResearchOpen Access04 Dec 2019
Blood Cancer Journal

Volume: 9, P: 1-9
Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

Arthur Bobin
Maéva Kyheng
Xavier Leleu
Research14 Oct 2021
Leukemia

Volume: 36, P: 881-884
Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia

Stephan Stilgenbauer
Thérèse Aurran Schleinitz
Thorsten Zenz
ResearchOpen Access14 May 2019
Leukemia

Volume: 33, P: 2531-2535
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

Jan A. Burger
Paul M. Barr
Thomas J. Kipps
ResearchOpen Access18 Oct 2019
Leukemia

Volume: 34, P: 787-798
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

Anke Maes
Ken Maes
Elke De Bruyne
ResearchOpen Access15 May 2019
British Journal of Cancer

Volume: 120, P: 1137-1146
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman
Claire Dearden
Francis Giles
ResearchOpen Access20 Jul 2018
Leukemia

Volume: 32, P: 1768-1777
Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation

Ans Rombout
Sofie Lust
Jan Philippé
ResearchOpen Access25 Feb 2016
British Journal of Cancer

Volume: 114, P: 704-712